Consistent with complete tumor elimination by 2-weeks of CAR T cell infusion with no sign of relapse, IL-6 and IL-8 dropped to below 2 pg/ml in CAR T cohorts with or without PEN-221 treatment. This evidence concerns the gene CXCL8 and neoplasm.